Thyrocare Technologies (BOM:539871) Total Current Assets : ₹3,377 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Thyrocare Technologies's total current assets for the quarter that ended in Mar. 2025 was ₹3,377 Mil.

Thyrocare Technologies Total Current Assets Historical Data

The historical data trend for Thyrocare Technologies's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Total Current Assets Chart

Thyrocare Technologies Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Current Assets

Get a 7-Day Free Trial

2,404.40

2,700.20

2,729.40

2,785.10

3,377.20

Thyrocare Technologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Current Assets	Get a 7-Day Free Trial															2,785.10	-	2,448.40	-	3,377.20

Thyrocare Technologies Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Thyrocare Technologies's Total Current Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1929.9	+	465.4	+	730	+	251.9
	=	3,377

Thyrocare Technologies's Total Current Assets for the quarter that ended in Mar. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1929.9	+	465.4	+	730	+	251.9
	=	3,377

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Thyrocare Technologies (BOM:539871) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Thyrocare Technologies's Liquidation Value for the quarter that ended in Mar. 2025 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1929.9	-	1457	+	0.75 * 465.4	+	0.5 * 730
=	1,187

Thyrocare Technologies Total Current Assets Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Thyrocare Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (BOM:539871) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

THYROCARE:India

Address

D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703

Website

https://www.thyrocare.com

Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies Headlines

No Headlines